title: Ameliorative effect of allopurinol on nonbacterial prostatitis: a parallel double-blind controlled study.
abstract: OBJECTIVE
  Nonbacterial prostatitis is a common problem in young men. It is a disease that is often recurrent and each episode lasts for several months. Different causative mechanisms of the disease have been discussed, including identified and unidentified microorganisms, stone formation and psychological factors. We have demonstrated in a previous study that urinary reflux (as shown by a high creatinine concentration in prostatic fluid) occurs to a varying extent into the prostatic ducts, and this reflux has been related to prostatic pain and urate concentration in expressed prostatic secretion.
  
  
  METHODS
  We performed a paralled double-blind controlled study of the objective and subjective effects of allopurinol on patients with nonbacterial prostatitis. Twenty patients received placebo, 18 received 300 mg. allopurinol daily and 16 received 600 mg allopurinol daily for 240 days. All patients began medication at the same time regardless of whether the disease was in an active state. No side effects were noted in the treatment groups.
  
  
  RESULTS
  Significant effects were noted on the concentrations of serum urate, urine urate, expressed prostatic secretion urate, expressed prostatic secretion xanthine and subjective discomfort.
  
  
  CONCLUSIONS
  Allopurinol has a significant, positive effect on nonbacterial prostatitis. It is safe and worthy of trial for all at least a 3-month period at each episode to relieve the symptoms of nonbacterial prostatitis.
authors.affiliation: Department of Urology, University Hospital, Uppsala, Sweden.
authors.forename: B E
authors.initials: BE
authors.lastname: Persson
authors.forename: G
authors.initials: G
authors.lastname: Ronquist
authors.forename: M
authors.initials: M
authors.lastname: Ekblom
mesh_terms: D000493:Allopurinol / Q000627:therapeutic use*; D000963:Antimetabolites / Q000627:therapeutic use*; D004311:Double-Blind Method; D006801:Humans; D008297:Male; D011472:Prostatitis / Q000188:drug therapy* / Q000378:metabolism
chemical_list: D000963:Antimetabolites; D000493:Allopurinol